ArticleBMC cancer2017

Use of the QIAGEN GeneReader NGS system for detection of KRAS mutations, validated by the QIAGEN Therascreen PCR kit and alternative NGS platform.

Agus Darwanto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.